Exicure Inc
2H0
Company Profile
Business description
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Contact
400 Seaport Court
Suite 102
Redwood CityCA94063
USAT: +1 847 673-1700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
8
Stocks News & Analysis
stocks
3 global ‘buy the dip’ candidates with wide moats
Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.
stocks
What next for Nine Entertainment after Domain payout?
The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,128.70 | 18.10 | 0.20% |
CAC 40 | 7,825.24 | 1.72 | 0.02% |
DAX 40 | 23,698.15 | 5.50 | -0.02% |
Dow JONES (US) | 45,834.22 | 273.78 | -0.59% |
FTSE 100 | 9,283.29 | 14.29 | -0.15% |
HKSE | 26,388.16 | 301.84 | 1.16% |
NASDAQ | 22,141.10 | 98.03 | 0.44% |
Nikkei 225 | 44,768.12 | 395.62 | 0.89% |
NZX 50 Index | 13,227.90 | 1.25 | -0.01% |
S&P 500 | 6,584.29 | 3.18 | -0.05% |
S&P/ASX 200 | 8,864.90 | 22.00 | 0.25% |
SSE Composite Index | 3,870.60 | 4.71 | -0.12% |